New Tubes Designed for Medium Sample Volumes
|
By LabMedica International staff writers Posted on 03 Aug 2016 |

Image: The new 5.0 mL tube with screw cap (Photo courtesy of Eppendorf).
At the 2016 AACC annual meeting, Eppendorf (Hauppauge, NY, USA) will introduce a new 5 mL tube with a screw cap which fills the gap between existing tube formats and represents a novel option for working with medium–sized sample volumes.
The new 5.0 mL Tube will complement the application spectrum of sample processing in the medium volume range: in addition to sample processing, it can also be used for secure transport, long term storage at temperatures as low as -86 °C, and sample incubation at up to 100 °C. In addition to a secure seal, the grooved and multi-surface side contours of the newly designed screw cap ensure a slip-free grip. To accommodate individual laboratory protocols, it is available in Eppendorf Quality, PCR clean, Sterile, and Eppendorf Biopur purity grades.
Features include an ergonomic snap cap for single-handed operation; a screw cap with flattened end and grooved sides to provide optimal grip and user-friendly handling; a high-quality and transparent polypropylene construct free of plasticizers, biocides, or mold release agents; safety and stability for centrifugation up to 25,000 g; a conical shape compatible with accessories for conical 15 mL tubes; and caps made of proprietary LoBind material for maximum recovery of valuable samples. The new 5.0 mL Tube with screw cap will be presented at AACC 2016.
The American Association for Clinical Chemistry (AACC; Washington, DC, USA) is an international scientific/medical society of over 8,000 clinical laboratory professionals, physicians, research scientists and more. The AACC annual meeting, which will be held this year from July 31st to August 4th at the Pennsylvania Convention Center in Philadelphia (USA), features five days of educational sessions about scientific, clinical, technical and management challenges facing laboratory professionals, as well as the world’s largest Clinical Lab Expo.
Related Links:
Eppendorf
American Association for Clinical Chemistry
The new 5.0 mL Tube will complement the application spectrum of sample processing in the medium volume range: in addition to sample processing, it can also be used for secure transport, long term storage at temperatures as low as -86 °C, and sample incubation at up to 100 °C. In addition to a secure seal, the grooved and multi-surface side contours of the newly designed screw cap ensure a slip-free grip. To accommodate individual laboratory protocols, it is available in Eppendorf Quality, PCR clean, Sterile, and Eppendorf Biopur purity grades.
Features include an ergonomic snap cap for single-handed operation; a screw cap with flattened end and grooved sides to provide optimal grip and user-friendly handling; a high-quality and transparent polypropylene construct free of plasticizers, biocides, or mold release agents; safety and stability for centrifugation up to 25,000 g; a conical shape compatible with accessories for conical 15 mL tubes; and caps made of proprietary LoBind material for maximum recovery of valuable samples. The new 5.0 mL Tube with screw cap will be presented at AACC 2016.
The American Association for Clinical Chemistry (AACC; Washington, DC, USA) is an international scientific/medical society of over 8,000 clinical laboratory professionals, physicians, research scientists and more. The AACC annual meeting, which will be held this year from July 31st to August 4th at the Pennsylvania Convention Center in Philadelphia (USA), features five days of educational sessions about scientific, clinical, technical and management challenges facing laboratory professionals, as well as the world’s largest Clinical Lab Expo.
Related Links:
Eppendorf
American Association for Clinical Chemistry
Latest AACC 2016 News
- Molecular Test Detects Three Arboviruses in Plasma Samples
- Derived Exosomal Protein Biomarkers in Alzheimer’s Disease Diagnosis
- New Biochip Array Developed for ApoE4 Classification
- Cell-Free DNA Identifies Liver Transplant Patients with Acute Rejection
- New Method Tested for Early Diagnosis Pediatric Diabetic Nephropathy
- FDA-Cleared Automated Cell Counter for CSF Launched at AACC 2016
- Semen Analysis Portfolio with Two New Products Featured at AACC 2016
- Automation Solutions for Clinical Diagnostic Equipment Showcased at AACC 2016
- Multi Sample Osmometer Improves Testing Efficiency
- Innovative Information System Optimizes Laboratory Processes
- Innovative eLearning Interface Seamlessly Connects Competency Data
- Cloud-Based Connectivity Platform Advances Decentralized Healthcare
- Adhesives Research to Present Hydrophilic Adhesive Technologies
- Point-of-Care Immunoassay Analyzer on Display at AACC Annual Meeting
- Assay for Determination of 17-OH Progesterone to Be Featured at AACC Annual Meeting
- Fully Automated HbA1c Analyzer Available for Inspection at AACC Annual Meeting
Channels
Clinical Chemistry
view channel
Urine-Based Test Shows Promise for Autism Screening in Children
Autism spectrum disorder (ASD) is commonly diagnosed through behavioral assessments, which can involve long waits that delay intervention. Earlier identification is linked to better developmental outcomes,... Read more
Liquid Biopsy Biomarkers May Improve Childhood Epilepsy Diagnosis
Childhood epilepsy remains a major neurological disorder with unmet needs for accurate, non-invasive biomarkers, as conventional tests such as electroencephalography and neuroimaging can have limited sensitivity... Read moreMolecular Diagnostics
view channel
Updated Guidance Prioritizes Stool-Based Colorectal Cancer Screening Tests
Colorectal cancer is the second-leading cause of cancer death in the United States and claimed an estimated 55,000 lives in 2026. Incidence is rising among adults younger than 50, even as overall mortality... Read more
Digital PCR Assays Support Surveillance of Bundibugyo Ebolavirus Outbreak
QIAGEN (Venlo, Netherlands) has introduced two custom-designed research-use-only (RUO) QIAcuity dPCR assays to support infectious disease research and surveillance connected to the Bundibugyo ebolavirus outbreak.... Read more
Blood-Based Proteomic Test May Predict Treatment Response in Non-Small Cell Lung Cancer
Lung cancer remains the leading cause of cancer death, with non-small cell lung cancer (NSCLC) accounting for most cases. Treatment decisions are often made without a clear indication of how a patient... Read moreHematology
view channel
Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows
Sysmex America (Chicago, IL, USA) has introduced the next generation XR-Series, centered on the XR-10 Automated Hematology Module for high-complexity laboratories. The platform builds on the widely used... Read more
Blood Eosinophil Count May Predict Cancer Immunotherapy Response and Toxicity
Immune checkpoint inhibitors have improved outcomes across many cancers, yet only a subset of patients derive durable benefit and biomarkers to guide treatment remain limited. Eosinophils, best known for... Read moreImmunology
view channel
Metabolic Biomarker Distinguishes Latent from Active Tuberculosis and Tracks Treatment Response
Tuberculosis (TB) remains the world’s leading infectious killer, with 10.8 million cases and 1.25 million deaths recorded globally in 2023. Yet many infected individuals never develop active disease, underscoring... Read more
Immune Enzyme Linked to Treatment-Resistant Inflammatory Bowel Disease
Inflammatory bowel disease (IBD) affects nearly 3 million people in the United States and its prevalence continues to rise. Medications that target tumor necrosis factor (TNF)-alpha are widely used, but... Read moreMicrobiology
view channel
Gut Microbiome Signatures Help Identify Risk of IBD Progression
Inflammatory bowel disease (IBD), encompassing Crohn’s disease and ulcerative colitis, is a chronic relapsing inflammatory disorder of the gastrointestinal tract with highly variable outcomes.... Read more
FDA-Cleared Gastrointestinal Panel Detects 24 Pathogen Targets
Clinical guidelines support testing based on patient presentation in suspected gastrointestinal infections, yet available technologies have often forced laboratories to choose between panels that are too... Read morePathology
view channel
AI-Powered Atlas Maps Immune Structures Linked to Cancer Outcomes
Tertiary lymphoid structures are emerging as important indicators of antitumor immunity, but their heterogeneity and spatial context within tumors remain difficult to capture through routine diagnostics.... Read more
AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy
Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read moreTechnology
view channel
Mailed Screening Kits Help Reduce Colorectal Cancer Screening Gaps
Colorectal cancer screening is a longstanding preventive priority, yet participation and follow-up remain uneven across patient groups. Safety‑net primary care settings often face barriers that limit screening... Read more
Algorithm Panel Aids Liver Fibrosis Assessment and Liver Cancer Surveillance
Chronic liver disease is common and often progresses silently, increasing the risk of cirrhosis and hepatocellular carcinoma when not detected early. With an estimated 1.5 billion people affected worldwide... Read moreIndustry
view channelWerfen and Oxford Nanopore Collaborate on Transplant Assay Development
Werfen (Barcelona, Spain), a global specialized diagnostics company, has announced a strategic collaboration with Oxford Nanopore Technologies (Oxford, UK), which develops nanopore-based sequencing technology,... Read more





.jpg)



